Share on facebook Share on Twitter Share on Google Plus Share This
Back to Results

Practice patterns and outcomes of ACTHar use in children with nephrotic syndrome

Title Practice patterns and outcomes of ACTHar use in children with nephrotic syndrome
Therapeutic Area Nephrotic Syndrome (Floating)
Principal Investigator Lawrence Milner, MD
Min Age 0 Years
Max Age 21 Years
Gender All
Contact Lawrence Milner, mD
617 636-7016

Overview

This is a registry study which will collect safety health information from children 6 months to 21 years of age with nephrotic syndrome of any cause, and treated with ACTHar therapy. All the data collection will take place during the routine hospital visits. There is no additional visits and invasive procedures for this study.

Study Details

Inclusion Criteria

  • Children 6 months to 21 years of age with nephrotic syndrome of any cause
  • Treated with ACTHar therapy.

Exclusion Criteria

Study Requirements

This is a registry study which will collect safety information only. No additional research visits. no invasive procedures.